Is it good to buy Pfizer stock? (2024)

Is it good to buy Pfizer stock?

But with a strategy in place and acquisitions helping to bolster its prospects, investors should feel confident that the company is on a good path forward. Pfizer's high yield and low valuation -- the stock trades at an estimated 12 times its expected future earnings -- makes for a very attractive opportunity.

Is it good to invest in Pfizer?

Should You Buy Pfizer Stock? The worst of the slowdown looks to be over for Pfizer, and its non-COVID portfolio is growing at a reasonably good pace. Analysts expect its revenues to rise 2% and 5.6%, respectively, in 2024 and 2025, while its earnings per share are expected to rise 48% and 22% in these years.

Is Pfizer stock projected to go up?

Pfizer Stock Forecast

The 16 analysts with 12-month price forecasts for Pfizer stock have an average target of 36.88, with a low estimate of 27 and a high estimate of 50. The average target predicts an increase of 34.80% from the current stock price of 27.36.

Is Pfizer good to invest in 2024?

For 2024, Pfizer expects adjusted earnings of $2.05 to $2.25 per share and $58.5 billion to $61.5 billion in sales. At the midpoints, earnings would climb almost 17% as sales rise almost 3%.

What is the future of Pfizer share?

PFE Stock 12 Months Forecast

Based on 17 Wall Street analysts offering 12 month price targets for Pfizer in the last 3 months. The average price target is $31.18 with a high forecast of $45.00 and a low forecast of $27.00.

Is Pfizer a good buy long term?

However, the company's long-term prospects are actually quite good. Sure, it will take a few years for Pfizer's growth to fully kick in. However, the big drugmaker will pay you handsomely to wait, with a dividend yield of close to 6%.

Is Pfizer a buy hold or sell?

Pfizer stock has received a consensus rating of hold. The average rating score is A2 and is based on 24 buy ratings, 39 hold ratings, and 0 sell ratings. What was the 52-week low for Pfizer stock? The low in the last 52 weeks of Pfizer stock was 25.62.

What will Pfizer stock be worth in 5 years?

What are analysts saying about Pfizer stock?

Based on analysts offering 12 month price targets for PFE in the last 3 months. The average price target is $31.44 with a high estimate of $45 and a low estimate of $27.04.

What is the target price for Pfizer?

Is Pfizer dividend safe?

Pfizer Has A Solid Track Record

Even over a long history of paying dividends, the company's distributions have been remarkably stable. The annual payment during the last 10 years was $0.96 in 2013, and the most recent fiscal year payment was $1.64.

Is Pfizer over or undervalued?

Pfizer is an undervalued pharma stock that trades at a low multiple, providing investors with a margin of safety. Part of a recession-resistant sector, it has raised dividends by more than 7% annually in the last 25 years, enhancing your effective yield over time.

Why is Pfizer stock losing?

Pfizer's sales tanked 41% in Q4

Revenue was down to just $14.2 billion, declining by more than 41% year over year. And the company also incurred a $3.4 billion net loss, largely due to a revenue reversal involving Paxlovid, its COVID pill.

Who has the biggest share in Pfizer?

Its top three individual shareholders are Frank A. D'Amelio, Mikael Dolsten, and Albert Bourla. The top three institutional investors in Pfizer are Vanguard, BlackRock, and State Street.

What will Pfizer price be in 2025?

Pfizer stock price stood at $27.66

According to the latest long-term forecast, Pfizer price will hit $30 by the middle of 2025 and then $35 by the middle of 2027. Pfizer will rise to $40 within the year of 2028, $45 in 2029, $50 in 2030, $55 in 2033 and $60 in 2035.

Is AMZN a buy right now?

Amazon's analyst rating consensus is a Strong Buy. This is based on the ratings of 41 Wall Streets Analysts.

Why is Pfizer so cheap?

Pfizer is a cheap stock trading at a valuation well below the broader market. The company has experienced declining revenue and earnings over the past year as Covid-19 product sales have dropped.

What is Pfizer company weakness?

Weaknesses. Revenue Volatility Post-COVID-19: Pfizer Inc faced a significant operational decrease in revenue, primarily due to the reduction in COVID-19 product sales. This volatility highlights a weakness in the company's dependence on pandemic-related products for a substantial portion of its revenue.

How many years has Pfizer raised its dividend?

( PFE ) has increased its dividends for 15 consecutive years.

What is best stock to buy today?

How often does Pfizer pay dividends?

When is Pfizer dividend payment date? Pfizer's next quarterly payment date is on Mar 01, 2024, when Pfizer shareholders who owned PFE shares before Jan 25, 2024 received a dividend payment of $0.42 per share. Add PFE to your watchlist to be reminded of PFE's next dividend payment.

What company is Pfizer trying to buy?

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announces that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, expired December 11, 2023, with respect to Pfizer's pending acquisition of Seagen Inc. (NASDAQ: SGEN).

What was the price of Pfizer stock in 1995?

The closing price for Pfizer (PFE) in 1995 was $4.13, on December 29, 1995. It was up 67.5% for the year.

What medicine does Pfizer make?

How much profit has Pfizer made since COVID?

The ongoing Covid-19 pandemic propelled pharmaceutical company Pfizer's earnings to a record $100 billion last year, almost $57 billion of which was driven by its vaccine and antiviral pill Paxlovid, the company reported Tuesday.